Founded in 1960, Cipan is a company committed to health, and this has been demonstrated in its more than 50-year history
Cipan has developed, either through its own investment or through CDO strategies, three generations of APIs derived from Tetracycline: Tetracycline, Minocycline, Lymecycline, Oxytetracycline, and other third-generation molecules that are currently in commercial phase (CMO) or development (CDO).
Cipan is one of the top 3 companies in producing APIs through fermentation processes, or chemical synthesis processes, which makes it very versatile and the right partner to understand the needs of any client.
Its wide international presence gives Cipan the proven ability to manufacture according to the most demanding standards required by top-level agencies such as the EMA, FDA or CFDA.
In addition, Cipan has its own Registry department which combines knowledge of the entire value chain of the life cycle of a medicine, from its development to the preparation of the regulatory dossier for its commercialization.
Cipan’s competitive edge
- API PRODUCTION BY FERMENTATION AND ORGANIC SYNTHESIS
- FDA AND EUROPEAN INSPECTED FACILITIES
- CONTRACT DEVELOPMENT AND MANUFACTURING CAPABILITIES
- KNOWLEDGE OF THE API WORLDWIDE MARKET
- FAST PROTOTYPING OF INDUSTRIAL PROCESSES THROUGH PILOT PLANT FACILITIES
Our mission is to support our clients by incorporating integrity and quality to the research, development and production of our active pharmaceutical ingredients.
Since 2016 Cipan is part of the SUANFARMA group, which is specialized in the development, production & commercialization of ingredients for the pharmaceutical, veterinary & nutritional sectors.
- TETRACYCLINE HCI
- OXYTETRACYCLINE HCI
- MINOCYCLINE HCI
Cipan has comprehensive expertise in the chemistry of Tetracyclines and other complex molecules which endows Cipan with a robust technological platform that can be used to leverage our clients’ projects and hence their competitiveness.
Cipan has a deep understanding of biologic processes including downstream processing and purification as well as a comprehensive expertise in a wide range of fermentations using many different types of microorganisms.
Cipan has GMP certification for the manufacture of medicines for human and veterinary use and has successfully received inspections from the EMA and FDA that enable it to sell our products in Europe and the USA.
Cipan has recently been approved with the certification of the environmental management system according to the ISO 14001 standard achieved in January 2020 with the recognition by the certifying entity (APCER) that CIPAN has an implemented system that complies with the standard, responding to a requirement expressed in Environmental License.